Puma Biotechnology, Inc. (PBYI)
9.55
+0.14
(+1.49%)
USD |
NASDAQ |
Sep 04, 16:00
9.55
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Price : 9.55 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 9.40 | 9.637 | 9.305 | 9.55 | 185912.0 |
| Sep 03, 2026 | 9.72 | 9.72 | 9.37 | 9.41 | 244320.0 |
| Sep 02, 2026 | 9.40 | 9.735 | 9.28 | 9.69 | 411940.0 |
| Sep 01, 2026 | 9.11 | 9.59 | 9.11 | 9.35 | 458304.0 |
| Aug 31, 2026 | 9.02 | 9.20 | 8.78 | 9.11 | 242883.0 |
| Aug 28, 2026 | 9.24 | 9.26 | 9.02 | 9.06 | 235040.0 |
| Aug 27, 2026 | 9.01 | 9.30 | 8.95 | 9.24 | 202716.0 |
| Aug 26, 2026 | 9.31 | 9.31 | 9.04 | 9.16 | 374470.0 |
| Aug 25, 2026 | 9.22 | 9.38 | 9.17 | 9.32 | 303444.0 |
| Aug 24, 2026 | 9.30 | 9.30 | 8.99 | 9.12 | 266136.0 |
| Aug 21, 2026 | 9.20 | 9.475 | 9.07 | 9.24 | 333621.0 |
| Aug 20, 2026 | 9.45 | 9.45 | 9.03 | 9.11 | 390262.0 |
| Aug 19, 2026 | 9.33 | 9.51 | 9.25 | 9.49 | 262892.0 |
| Aug 18, 2026 | 8.80 | 9.34 | 8.80 | 9.24 | 244699.0 |
| Aug 17, 2026 | 8.80 | 8.99 | 8.621 | 8.82 | 191915.0 |
| Aug 14, 2026 | 8.84 | 8.885 | 8.53 | 8.83 | 233032.0 |
| Aug 13, 2026 | 8.93 | 8.965 | 8.65 | 8.71 | 263053.0 |
| Aug 12, 2026 | 9.01 | 9.23 | 8.775 | 8.90 | 372144.0 |
| Aug 11, 2026 | 8.77 | 8.91 | 8.48 | 8.77 | 314597.0 |
| Aug 10, 2026 | 8.955 | 8.955 | 8.55 | 8.69 | 437957.0 |
| Aug 07, 2026 | 8.15 | 9.400 | 8.12 | 8.91 | 683333.0 |
| Aug 06, 2026 | 8.02 | 8.16 | 7.86 | 8.12 | 539151.0 |
| Aug 05, 2026 | 7.84 | 8.08 | 7.82 | 7.99 | 237978.0 |
| Aug 04, 2026 | 7.71 | 7.83 | 7.63 | 7.80 | 269420.0 |
| Aug 03, 2026 | 7.98 | 7.995 | 7.41 | 7.69 | 338516.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arcutis Biotherapeutics, Inc. | 23.90 |
| ACADIA Pharmaceuticals, Inc. | 28.02 |
| Alnylam Pharmaceuticals, Inc. | 266.11 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
Price Related Metrics
| PE Ratio | 18.50 |
| PS Ratio | 2.126 |
| Price to Book Value | 3.523 |
| Price to Free Cash Flow | 11.94 |
| Earnings Yield | 5.41% |
| Market Cap | 488.03M |
| Operating PE Ratio | 16.15 |
| Normalized PE Ratio | 18.49 |